The organiser of the Tour of Ayrshire has released details of the closed-roads time trial events, due to take place on Saturday April 29, in Kilmarnock.
Covering a 20km (12.4-mile) course, the time trial events comprise an individual test against the clock and a four-rider team competition.
The route heads north-east from Kilmarnock's Kay Park and into the countryside before returning to the finish at St Joseph’s Academy.
The individual event counts as a qualifier for the 2017 UCI Gran Fondo World Championships time trial, with the top 25 per cent of finishers qualifying for a place in the World Championships.
"This is a new event on the Scottish calendar but is open to riders from all over," said Tom Caldwell of event organiser Golazo Cycling.
Watch: How to beat long time trials
Get The Leadout Newsletter
The latest race content, interviews, features, reviews and expert buying guides, direct to your inbox!
"The ToA Chrono is a UCI Gran Fondo World Championship qualifying event and is expected to draw competitors in from around the world. The same event at the Tour of Cambridgeshire attracts over 800 riders, at least 20 per cent from overseas and sells out in a few hours. Given the appetite for time trailing in Scotland, we have high hopes that this will be a popular event."
The individual Chrono time trial starts from 10am on April 29, and is open to 500 competitors. The afternoon hosts the Team Chrono event, which is open to teams of four riders: male, female, mixed or corporate. Note that the team event is not a qualifying event for the Gran Fondo World Championships.
Nigel Wynn worked as associate editor on CyclingWeekly.com, he worked almost single-handedly on the Cycling Weekly website in its early days. His passion for cycling, his writing and his creativity, as well as his hard work and dedication, were the original driving force behind the website’s success. Without him, CyclingWeekly.com would certainly not exist on the size and scale that it enjoys today. Nigel sadly passed away, following a brave battle with a cancer-related illness, in 2018. He was a highly valued colleague, and more importantly, an exceptional person to work with - his presence is sorely missed.
